N@N

Incyte to Present at the 27th Annual JPMorgan Healthcare Conference

^{Published on 2009-01-05 13:45:03, Last Modified on 2009-01-05 13:45:24 - Market Wire}
 

WILMINGTON, Del.--([ BUSINESS WIRE ])--Incyte Corporation (Nasdaq:INCY) announced today it will present at the 27^th Annual JPMorgan Healthcare Conference on Tuesday, January 13, 2009 at 3:30 p.m. (Pacific Time) / 6:30 p.m. (Eastern Time).

Paul Friedman, M.D., president and chief executive officer of Incyte, will provide an overview of the company and discuss its most advanced drug discovery and development programs.

The presentation will be webcast live and can be accessed at [ www.incyte.com ] under Investor Relations, Events and Webcasts. A replay of the presentation will be available for 30 days. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Incyte's pipeline includes multiple compounds in Phase I and Phase II development for oncology, inflammation and diabetes.